The potential use of MMP inhibitors in AD is very speculative and is based on the seemingly beneficial effect of MMP-9, due to its role in degradation of amyloid plaques and hence its contribution to the clearance of Aβ from the brain. Here, MMP9 is linked to Alzheimer disease.